International Cancer Organizations Present Collaborative Work During Oncology Event in China

November 15, 2024 12:04 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO).

XI'AN, China, Nov. 15, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is taking part in the Fourth International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO) sponsored by the China Anti-Cancer Association (CACA), Chinese Institute of Development Strategy on Holistic Integrative Medicine, and Asian Oncology Society (AOS). The three-day event highlights international collaborations to improve cancer treatment and outcomes across China and beyond.

"NCCN is honored to participate in this important meeting," said Wui-Jin Koh, MD, Chief Medical Officer, NCCN. "China is one of the top three countries in the world in terms of number of registered users for our website and downloads of NCCN Guidelines. We are grateful that our evidence-based expert consensus-driven recommendations are being utilized to guide and improve care for people with cancer throughout China and all of Asia."

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) help define and advance high-quality, high-value, patient-centered cancer care globally. There are 88 different NCCN Guidelines®, featuring recommendations from multi-disciplinary expert panels for treating nearly the vast majority of cancer types, plus screening, prevention, and supportive care. They are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. NCCN Guidelines were downloaded more than 15 million times in 2023 worldwide, with nearly a million downloads from China alone.

NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives. NCCN is pleased to collaborate with leading oncology groups in China, including:

  • Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm
    • Through this ongoing collaboration, NCCN works with leading gynecologic experts in China to translate, adapt, and update NCCN Guidelines for Gynecologic Cancers, including Cervical Cancer, Gestational Trophoblastic Neoplasia, Ovarian Cancer, Uterine Neoplasms, and Vulvar Cancer.
  • Medlive

NCCN's resources are available for free to people everywhere, including more than 100,000 registered users in China. NCCN Guidelines have been translated more than 250 times across approximately 50 languages, including 30 NCCN Guidelines in Chinese. The NCCN Global Program also provides free access to International Adaptations, NCCN Framework for Resource Stratification (NCCN Framework™), and NCCN Harmonized Guidelines™, which feature pragmatic approaches for defining appropriate treatment tailored to unique regional circumstances. Learn more and access all of these materials by visiting NCCN.org/global

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

Media Contact:
Rachel Darwin
267-622-6624
[email protected]

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.